Evidence map›Paper›PMID 40627160›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2025

AI lesion tracking in PET/CT imaging: a proposal for a Siamese-based CNN pipeline applied to PSMA PET/CT scans.

Stefan P Hein, Manuel Schultheiss, Andrei Gafita, Raphael Zaum, Farid Yagubbayli, Robert Tauber, Isabel Rauscher, Matthias Eiber, Franz Pfeiffer, Wolfgang A Weber

Abstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Automated lesion tracking and treatment response classification on [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Stefan P HeinDepartment of Nuclear Medicine, School of Medicine and Health, TUM Klinikum, Technical University of Munich, Munich, 81675, Germany. stefan.hein@tum.de.ORCID 0009-0009-4160-5763
Manuel SchultheissChair of Biomedical Physics, Department of Physics, TUM School of Natural Sciences, Technical University of Munich, Garching, 85748, Germany.
Andrei GafitaDivision of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, 21205, MD, USA.
Raphael ZaumDepartment of Nuclear Medicine, School of Medicine and Health, TUM Klinikum, Technical University of Munich, Munich, 81675, Germany.
Farid YagubbayliChair of Biomedical Physics, Department of Physics, TUM School of Natural Sciences, Technical University of Munich, Garching, 85748, Germany.
Robert TauberDepartment of Urology, School of Medicine and Health, TUM Klinikum, Technical University of Munich, Munich, 81675, Germany.
Isabel RauscherDepartment of Nuclear Medicine, School of Medicine and Health, TUM Klinikum, Technical University of Munich, Munich, 81675, Germany.
Matthias EiberDepartment of Nuclear Medicine, School of Medicine and Health, TUM Klinikum, Technical University of Munich, Munich, 81675, Germany.
Franz Pfeiffer *Chair of Biomedical Physics, Department of Physics, TUM School of Natural Sciences, Technical University of Munich, Garching, 85748, Germany.
Wolfgang A Weber *Department of Nuclear Medicine, School of Medicine and Health, TUM Klinikum, Technical University of Munich, Munich, 81675, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAssessing tumor response to systemic therapies is one of the main applications of PET/CT. Routinely, only a small subset of index lesions out of multiple lesions is analyzed. However, this operator dependent selection may bias the results due to possible significant inter-metastatic heterogeneity of response to therapy. Automated, AI-based approaches for lesion tracking hold promise in enabling the analysis of many more lesions and thus providing a better assessment of tumor response. This work introduces a Siamese CNN approach for lesion tracking between PET/CT scans.

methodsOur approach is applied on the laborious task of tracking a high number of bone lesions in full-body baseline and follow-up [

resultsExperiments have been performed with different input patch types and a Siamese network in 2D and 3D. The CNN model successfully learned to classify lesion assignments, reaching an accuracy of 83 % in its best configuration with an AUC = 0.91. For corresponding lesions the pipeline accomplished lesion tracking accuracy of even 89 %.

conclusionWe proved that a CNN may facilitate the tracking of multiple lesions in PSMA PET/CT scans. Future clinical studies are necessary if this improves the prediction of the outcome of therapies.

Indexed as

Convolutional Neural NetworksImage Processing, Computer-AssistedPositron Emission Tomography Computed TomographyAlgorithmsArtificial IntelligenceBone NeoplasmsComputer SimulationGallium IsotopesGallium RadioisotopesHumansImage Interpretation, Computer-AssistedImaging, Three-DimensionalMaleProstatic Neoplasms, Castration-ResistantWorkflowgallium 68 PSMA-11Gallium IsotopesGallium RadioisotopesAICNNLesion trackingMetastatic castration resistant prostate cancerPET/CTPSMA

Identifiers

PMID40627160
PMCPMC12660441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.